MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$13,534K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales and maturiti...
Stock-based compensation expense
Other long-term assets
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Net loss
Accrued expenses and other liabi...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Stock-based compensation expense
15,660
Net loss
-111,866
Amortization of discount on marketable securities
1,423
Prepaid expenses and other current assets
1,389
Other receivable
8,105
Other long-term assets
-1,072
Accrued expenses and other liabilities
-15,526
Collaboration receivable - related party
7,136
Accounts payable
-12,007
Depreciation expense
216
Premium on marketable securities
295
Right-of-use operating asset
-796
Operating lease liabilities, non-current
-975
Operating lease liabilities, current
560
Net cash used in operating activities
-140,418
Proceeds from sales and maturities of marketable securities
283,376
Purchases of marketable securities
156,575
Net cash provided by investing activities
126,801
Proceeds from stock option exercises and employee stock purchase plan issuances
242
Payment of employee tax obligations related to vesting of restricted stock units
159
Net cash provided by financing activities
83
Net increase (decrease) in cash, cash equivalents and restricted cash
-13,534
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sales and
maturities of marketable...
$283,376K
Proceeds from stock
option exercises and...
$242K
Net cash provided by
investing activities
$126,801K
Net cash provided by
financing activities
$83K
Canceled cashflow
$156,575K
Canceled cashflow
$159K
Net increase
(decrease) in cash, cash...
-$13,534K
Canceled cashflow
$126,884K
Stock-based compensation
expense
$15,660K
Other long-term
assets
-$1,072K
Right-of-use operating asset
-$796K
Operating lease
liabilities, current
$560K
Depreciation expense
$216K
Purchases of marketable
securities
$156,575K
Payment of employee tax
obligations related to...
$159K
Net cash used in
operating activities
-$140,418K
Canceled cashflow
$18,304K
Net loss
-$111,866K
Accrued expenses and
other liabilities
-$15,526K
Accounts payable
-$12,007K
Other receivable
$8,105K
Collaboration receivable -
related party
$7,136K
Amortization of discount on
marketable securities
$1,423K
Prepaid expenses and
other current assets
$1,389K
Operating lease
liabilities, non-current
-$975K
Premium on marketable
securities
$295K
Buy us a coffee
Sage Therapeutics, Inc. (SAGE)
Sage Therapeutics, Inc. (SAGE)